Roche Holding AG (OTCMKTS:RHHBY) Short Interest Up 35.0% in May

Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 5,810,300 shares, a growth of 35.0% from the April 30th total of 4,303,900 shares. Currently, 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 4,822,800 shares, the days-to-cover ratio is presently 1.2 days.

Roche Stock Performance

Roche stock traded up $0.10 during trading hours on Friday, reaching $40.86. 978,646 shares of the company's stock were exchanged, compared to its average volume of 2,755,281. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. The firm's 50 day simple moving average is $39.14 and its 200 day simple moving average is $38.79. Roche has a twelve month low of $33.30 and a twelve month high of $44.31.

Institutional Trading of Roche

Large investors have recently bought and sold shares of the business. GAMMA Investing LLC grew its stake in Roche by 6,463.8% during the first quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock worth $21,759,000 after purchasing an additional 520,722 shares during the period. Boston Common Asset Management LLC grew its position in shares of Roche by 10.0% during the 1st quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock worth $13,369,000 after buying an additional 29,522 shares during the period. Altrius Capital Management Inc grew its position in shares of Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after buying an additional 6,545 shares during the period. Bard Financial Services Inc. grew its holdings in Roche by 25.3% in the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after purchasing an additional 28,050 shares during the period. Finally, Rhumbline Advisers grew its holdings in Roche by 7.4% in the first quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after purchasing an additional 7,374 shares during the period.

Analyst Ratings Changes

Several research analysts have recently issued reports on RHHBY shares. UBS Group raised Roche from a "hold" rating to a "strong-buy" rating in a research note on Thursday, February 13th. Hsbc Global Res cut shares of Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. Morgan Stanley initiated coverage on Roche in a report on Wednesday, February 12th. They issued an "equal weight" rating for the company. Finally, HSBC downgraded Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy".

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.